FDA declines to approve nasal spray alternative to EpiPen
In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.
September 22, 2023
"With the EpiPens, this is really the only route of epinephrine available for patients to be prescribed in an outpatient setting for use of anaphylactic reactions," said Lauren Frasier, the clinical pharmacy manager at Wesley Medical Center.
"The intranasal route might be able to be used a little more frequently for people that were on the fence about using an EpiPen just because of the way it's administered," she said. Frasier explained that other intranasal medications have been successful for seizures, drug overdose, and pain, for example.
Published:
September 22, 2023